STAT3 and lung carcinoma: These results clearly suggest that ACHP significantly downregulates the constitutive phosphorylation of STAT3 in lung cancer cells, as shown in Figure 1C. ACHP also clearly reduced the constitutive STAT3 DNA-binding activity, as shown in Figure 1D.